|
Dr. Paul Janssen Symposia Series
The New York Academy of Sciences is pleased to present this special series of five events, organized in partnership with The Dr. Paul Janssen Award for Biomedical Research. The Dr. Paul Janssen Award recognizes, promotes, and rewards passion and creativity in biomedical research in honor of the work of Dr. Paul Janssen, a prolific inventor who developed more than 80 medicines and over 100 patents over the course of his career. Janssen was the founder of Janssen Pharmaceutica, now part of the Johnson & Johnson Family of Companies.
The Symposia series shares the spirit with which Dr. Janssen undertook his research. His innovations spanned a wide range of fields within the biomedical sciences, with breakthrough medicines developed for pain management, psychiatry, infectious disease and gastroenterology—all realizing direct improvements in human health.
Click the links below for more information about each of the events in the series and for registration information. For more information about Dr. Janssen, his work, and the award that bears his name, please visit www.pauljanssenaward.com.
Events
Wednesday, January 20, 2010 | 1:00 PM - 5:45 PM
Organizers: Steven Gross (Weill Cornell Medical College) and Kyu Rhee (Weill Cornell Medical College)
This symposium will review recent technical and conceptual advances that highlight the unique, but largely unrecognized, potential of the metabolomics arm of systems biology.
Tuesday, February 23, 2010 | 1:00 PM - 5:00 PM
Speakers: Mark Bear (Massachusetts Institute of Technology), Bita Moghaddam (University of Pittsburgh), Colleen Niswender (Vanderbilt University School of Medicine), Jean-Philippe Pin (Université de Montpellier) and Jean-Philippe Rocher (Addex Pharmaceuticals)
This symposium will include detailed discussions of these unique GPCRs, considered by many to be the single most promising new collection of targets for CNS drug discovery.
Wednesday, March 17, 2010 | 1:00 PM - 5:00 PM
Speakers: Julian Adams (Infinity Pharmaceuticals Inc.), Andy McMahon (Harvard University), Kenneth Olive (Columbia University), Robert Yauch (Genentech, Inc.)
The Hedgehog Signaling Pathway regulates processes essential for embryo development, offering a novel approach to the treatment of some cancers. This meeting reviews its role in disease pathogenesis and discusses potential therapeutic opportunities.
Tuesday, April 6, 2010 | 1:00 PM - 5:30 PM
Speakers: Helena Boshoff (NIH), William R. Jacobs, Jr. (Albert Einstein College of Medicine), Carl Nathan (Weill Cornell Medical College), Christopher Sassetti (University of Massachusetts Medical School), and (Dirk Schnappinger) Weill Cornell Medical College
TB kills nearly 2 million people yearly, and now shows drug resistance. This symposium highlights how the genetic information of the pathogen and genetic tools are utilized in the quest for new TB drugs.
Monday, May 24, 2010 | 1:00 PM - 5:00 PM
Organizers: Doris Bucher (New York Medical College), Jennifer Henry (The New York Academy of Sciences)
Influenza viruses such as H1N1 continue to pose a major global public health problem, so understanding their pathogenicity and transmission is crucial. This symposium will revisit the 2009 outbreak and examine strategies against future outbreaks.
Publications
March 30, 2010
Organizers: Kyu Rhee and Steven Gross of Weill Cornell Medical College
Large-scale collection of data on metabolic changes provides insight into disease states and normal physiology. Researchers are exploring how to gather and use such information.
February 23, 2010
Speakers: Mark Bear (Massachusetts Institute of Technology), Bita Moghaddam (University of Pittsburgh), Colleen Niswender (Vanderbilt University School of Medicine), Jean-Philippe Pin (Université de Montpellier), and Jean-Philippe Rocher (Addex Pharmaceuticals)
Researchers met to discuss advances in basic and translational research on metabotropic glutamate receptors, which are promising targets in drug discovery for CNS diseases and other illnesses.
October 29, 2008
Speakers: Marc Feldmann and Sir Ravinder Maini (Imperial College London), Lawrence Steinman (Stanford University), Peter Lipsky (NIAMS), and Peter Barnes (NHLBI)
A symposium honored Ravinder Maini and Marc Feldmann, who revolutionized rheumatoid arthritis treatment with their development of anti-TNF therapy.
|
|